Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline
Danilo de Gregorio, Antonio Inserra, Justine P. Enns, Athanasios Markopoulos, Michael Pileggi, Youssef El Rahimy, Martha López-canul, Stefano Comai, Gabriella Gobbi
Neuropsychopharmacology March 17, 2022 DOI: 10.1038/s41386-022-01301-9 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical experimental study Peer reviewed |
|---|---|
| Population | Male mice exposed to chronic restraint stress |
| Intervention | Lysergic acid diethylamide (LSD) |
| Dose | 5, 15, 30, and 60 μg/kg (acute); 30 µg/kg daily for 7 days (repeated) |
| Duration | 7-day repeated administration |
| Topics | LSD Serotonin Anxiety |
| Keywords | Anxiolytic Dorsal raphe nucleus Agonist Antidepressant Neurotransmission Endocrinology Pharmacology Raphe nuclei Hippocampus |
| Citations | 89 |
| Key findings | Repeated LSD (30 µg/kg daily for 7 days) prevents stress-induced anxiety-like behavior and loss of cortical dendritic spines in male mice, while enhancing serotonin neuron firing and reducing 5-HT1A receptor sensitivity. |
Abstract
Lysergic acid diethylamide (LSD) is a serotonergic psychedelic compound receiving increasing interest due to putative anxiolytic and antidepressant properties. However, the potential neurobiological mechanisms mediating these effects remain elusive. Employing in vivo electrophysiology, microionthophoresis, behavioral paradigms and morphology assays, we assessed the impact of acute and chronic LSD administration on anxiety-like behavior, on the cortical dendritic spines and on the activity of serotonin (5-HT) neurons originating in the dorsal raphe nucleus (DRN) in male mice exposed to chronic restraint stress. We found that while the acute intraperitoneal (i.p.) administration of LSD (5, 15 and 30 and 60 μg/kg) did not produce any anxiolytic or antidepressant effects in non-stressed mice, the dose of 30 µg/kg (daily for 7 days) prevented the stress-induced anxiety-like behavior and the stress-induced decrease of cortical spine densitiy. Interestingly, while LSD acutely decreased the firing activity of 5-HT neurons, repeated LSD increased their basal firing rate and restored the low 5-HT firing induced by stress. This effect was accompanied by a decreased inhibitory response of 5-HT neurons to microiontophoretic applications of the 5-HT1A agonist 8-OH-DPAT (8-hydroxy-N,N-dipropyl-2-aminotetralin). In conclusion, repeated LSD prevents the exacerbation of anxiety-like behavior following chronic stress exposure, but has no behavioral effects in non-stressed mice. These effects are paralleled by increased cortical spinogenesis and an enhancement of 5-HT neurotransmission which might be due to 5-HT1A receptors desensitization. Increased cortical spine density and enhancement of serotonergic neurotransmission may thus represent a candidate mechanism which mediate the therapeutic effects of serotonergic psychedelics on stress-induced anxiety.
Comparable studies
Other preclinical and animal studies on LSD for anxiety, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression Rats | 2020 | Preclinical study | |
| Repeated microdoses of LSD do not alter anxiety or boldness in zebrafish. Zebrafish (Danio rerio) | 2024 | Experimental study | |
| Psychedelics Improve the Mental Health of Rats Male Wistar-Kyoto (WKY) rats | 2019 | Controlled experiment | n = 42 |
| Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice Mice | 2023 | Ethopharmacological study in mice | |
| Addressing the Current Knowledge and Gaps in Research SurroundingLysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in RodentModels Rodent models | 2023 | Review |
Citations in the library
Cited by 60
- Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 2023
- Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review Neuroscience & Biobehavioral Reviews September 1, 2022
- A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Cell Reports March 28, 2023
- Canalization and plasticity in psychopathology Neuropharmacology December 27, 2022
- Therapeutic mechanisms of psychedelics and entactogens. Neuropsychopharmacology July 24, 2023
and 55 more in the library
Cites 33
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Science August 19, 2010
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
and 28 more in the library